Gene therapy products, namely biopharmaceutical preparations, primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene for delivery to a cell or tissue, for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system; biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of rare genetic diseases, conditions and disorders of muscle or the central nervous system